免疫球蛋白κ轻链的N-糖基化热点与AL淀粉样变性相关
研究利用已发表的致淀粉样变性和对照克隆轻链序列,以及在本机构随访的220例AL淀粉样变性或多发性骨髓瘤患者的轻链序列信息,结合生物信息学、生化、蛋白质组学、结构和遗传学分析,定义N-糖基化的序列和空间特征。发现致淀粉样变性κ轻链的N-糖基化具有特殊的序列和空间模式,多数位点位于框架区3,尤其是E链内,且主要为NFT序列子,从而与非致淀粉样变性克隆轻链区分。数据进一步支持N-糖基化在决定部分致淀粉样变性轻链致病行为中的潜在作用,并可能有助于完善当前基于N-糖基化的单克隆丙种球蛋白病预后评估。
要点
- 致淀粉样变性κ轻链的N-糖基化位点主要位于框架区3的E链内。
- NFT序列子是致淀粉样变性κ轻链N-糖基化的主要序列子。
- N-糖基化可能参与决定部分致淀粉样变性轻链的致病行为。
核心结论
- 致淀粉样变性κ轻链具有特殊的N-糖基化序列和空间模式,多数位点位于框架区3尤其是E链内且主要为NFT序列子,与非致淀粉样变性克隆轻链不同。
- 数据进一步支持N-糖基化在决定部分致淀粉样变性轻链致病行为中的潜在作用,并可能有助于完善当前基于N-糖基化的单克隆丙种球蛋白病预后评估。
研究设计与样本
- 研究利用已发表的致淀粉样变性和对照克隆轻链序列信息,以及在本机构随访的220例AL淀粉样变性或多发性骨髓瘤患者的轻链序列信息。
- 研究结合生物信息学、生化、蛋白质组学、结构和遗传学分析,定义N-糖基化的序列和空间特征。
主要发现
- 致淀粉样变性κ轻链的N-糖基化位点多数位于框架区3,尤其是E链内。
- 致淀粉样变性κ轻链的N-糖基化位点主要为NFT序列子,与非致淀粉样变性克隆轻链不同。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immunoglobulin light chain (AL) amyloidosis is caused by a small, minimally proliferating B-cell/plasma-cell clone secreting a patient-unique, aggregation-prone, toxic light chain (LC). The pathogenicity of LCs is encrypted in their sequence, yet molecular determinants of amyloidogenesis are poorly understood. Higher rates of N-glycosylation among clonal κ LCs from patients with AL amyloidosis compared to other monoclonal gammopathies indicate that this post-translational modification is associated with a higher risk of developing AL amyloidosis. Here, we exploited LC sequence information from previously published amyloidogenic and control clonal LCs and from a series of 220 patients with AL amyloidosis or multiple myeloma followed at our Institutions to define sequence and spatial features of N-glycosylation, combining bioinformatics, biochemical, proteomics, structural and genetic analyses. We found peculiar sequence and spatial pattern of N-glycosylation in amyloidogenic κ LCs, with most of the N-glycosylation sites laying in the framework region 3, particularly within the E strand, and consisting mainly of the NFT sequon, setting them apart with respect to non-amyloidogenic clonal LCs. Our data further support a potential role of N-glycosylation in determining the pathogenic behavior of a subset of amyloidogenic LCs and may help refine current N-glycosylation-based prognostic assessments for patients with monoclonal gammopathies.
引用
- Nevone A, Girelli M, Mangiacavalli S, et al. An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis. Leukemia. 2022. PMID: 35610346. doi:10.1038/s41375-022-01599-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。